AstraZeneca Joins Pharma Investment Push in U.S. Amid Tariff Threat

AstraZeneca Joins Pharma Investment Push in U.S. Amid Tariff Threat

The British drug maker plans to invest $50 billion in the United States as it seeks to appease President Trump. continue reading...

Author
The New York Times

You May Also Like